Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 851-900 of 6028 result(s).
CYDY CytoDyn Inc
03/06/2024 3:52:50 PM
She headed up the FDA response to a (3)
CYDY CytoDyn Inc
03/06/2024 3:47:26 PM
we can sell a lawsuit before it rea (10)
CYDY CytoDyn Inc
03/06/2024 3:43:48 PM
the fda doesnt understand LL or at (6)
CYDY CytoDyn Inc
03/06/2024 3:41:46 PM
I would have been thrilled to know (9)
CYDY CytoDyn Inc
03/06/2024 3:33:45 PM
I feel it's worth pointing out that (11)
CYDY CytoDyn Inc
03/06/2024 3:31:14 PM
You're also ignoring the specific f (6)
CYDY CytoDyn Inc
03/06/2024 3:16:04 PM
It's a PITY... it's Less understood (14)
CYDY CytoDyn Inc
03/06/2024 3:05:24 PM
Do you like the primary endpoints t (24)
CYDY CytoDyn Inc
03/06/2024 2:00:42 AM
I'm sure whatever CRO we are using (10)
CYDY CytoDyn Inc
03/06/2024 1:56:12 AM
We did hit 100% receptor occupancy (13)
CYDY CytoDyn Inc
03/06/2024 1:43:06 AM
Amyloid is part of the problem...li (6)
CYDY CytoDyn Inc
03/06/2024 1:30:48 AM
First, with age, more CCR5 receptor (11)
CYDY CytoDyn Inc
03/06/2024 1:12:23 AM
Do you or anyone else have a link t (7)
CYDY CytoDyn Inc
03/06/2024 1:09:43 AM
f I heard Dr. Jay correctly... In a (7)
CYDY CytoDyn Inc
03/04/2024 9:53:14 PM
Ohm, given LL's innate science, I w (18)
CYDY CytoDyn Inc
03/04/2024 4:58:34 PM
Bumps up the immune response like l (13)
CYDY CytoDyn Inc
03/04/2024 12:39:34 PM
Sounds familiar. Maybe Ronk needs s (7)
CYDY CytoDyn Inc
03/03/2024 5:31:17 PM
BZE has not made one bashing post. (8)
CYDY CytoDyn Inc
03/03/2024 5:25:37 PM
Twice, years ago. No response on on (4)
CYDY CytoDyn Inc
03/03/2024 4:41:16 AM
He was definitely onboard with Lero (15)
CYDY CytoDyn Inc
03/03/2024 4:31:47 AM
Good article. But we found just the (19)
CYDY CytoDyn Inc
03/01/2024 1:08:50 AM
I should also add that by ChemR23 d (8)
CYDY CytoDyn Inc
03/01/2024 12:43:33 AM
Copycat of Leronlimab or just ahead (17)
CYDY CytoDyn Inc
02/26/2024 10:09:09 PM
Ohm, I saw that SSPE is not on your (12)
CYDY CytoDyn Inc
02/26/2024 11:54:24 AM
79% of Crohn's disease patients in (23)
CYDY CytoDyn Inc
02/21/2024 4:38:25 PM
Another downside of leronlimab not (10)
CYDY CytoDyn Inc
02/21/2024 4:31:54 PM
Someone in a PM introduced me to a (13)
CYDY CytoDyn Inc
02/21/2024 6:34:00 AM
He seems to feel that statins are e (13)
CYDY CytoDyn Inc
02/21/2024 12:15:31 AM
However, statins have also been im (8)
CYDY CytoDyn Inc
02/19/2024 10:54:09 PM
The F.D.A. can have a more flexible (12)
CYDY CytoDyn Inc
02/19/2024 10:43:56 PM
"Persist in latent reservoirs"...an (12)
CYDY CytoDyn Inc
02/19/2024 10:30:57 PM
You can't go really far into the we (11)
CYDY CytoDyn Inc
02/19/2024 10:38:11 AM
Wonder what Ohm thinks? Decent over (4)
CYDY CytoDyn Inc
02/19/2024 9:49:59 AM
This list appears to be related to (6)
CYDY CytoDyn Inc
02/19/2024 9:46:17 AM
do you think the new protocol will (10)
CYDY CytoDyn Inc
02/19/2024 12:36:36 AM
Quite a few of those chemokines are (21)
CYDY CytoDyn Inc
02/17/2024 4:11:09 PM
That being said, there will be NO c (17)
CYDY CytoDyn Inc
02/17/2024 3:36:37 PM
In many cases, the acquiring compan (15)
CYDY CytoDyn Inc
02/17/2024 12:53:07 AM
I have 3 bars and 25 years of exper (9)
CYDY CytoDyn Inc
02/17/2024 12:45:02 AM
From the what doesn't kill you will (8)
CYDY CytoDyn Inc
02/15/2024 6:57:54 AM
Example: every time Netflix makes a (11)
CYDY CytoDyn Inc
02/14/2024 3:54:59 PM
I'm curious what, if any, impact th (8)
CYDY CytoDyn Inc
02/14/2024 3:50:25 PM
He has been active with Amarex as a (6)
CYDY CytoDyn Inc
02/14/2024 3:42:02 PM
That treatment boosts Tregs, leronl (8)
CYDY CytoDyn Inc
02/14/2024 3:22:43 PM
but what good would that do if they (4)
CYDY CytoDyn Inc
02/14/2024 3:06:07 PM
I still maintain that we don't know (7)
CYDY CytoDyn Inc
02/14/2024 12:24:32 AM
I see these terms "stark"..."robust (3)
CYDY CytoDyn Inc
02/14/2024 12:19:04 AM
Leronlimab as use for immune activa (11)
CYDY CytoDyn Inc
02/12/2024 8:15:12 PM
Sounds like it’s a potential immu (14)
CYDY CytoDyn Inc
02/12/2024 5:59:54 PM
Can't argue with those points. I'll (7)
Go to page:
  • << First
  • < Previous
  • 17
  • 18
  • Next >

Recent Articles

  • Discover the Exciting Back-to-School Sale at AliExpress
  • Novo Nordisk's Wegovy Approval Sparks Investor Optimism
  • Saint James Iced Tea Joins Forces with 4ocean for Cleanup
  • Corporate Earnings Surge: A Deep Dive into the Magnificent Seven
  • Big Bold Health Introduces Immune Solutions at Erewhon Stores
  • Monaco Unveils Groundbreaking Trading Infrastructure for All
  • Elevating Digital Infrastructure: Michael Rechtin Joins Latham & Watkins
  • Explore the New Rail Connection to Coastal Mississippi Attractions
  • Innovative Safety Device Enhances Mobility Chair Performance
  • VantageScore 4.0: The Game Changer in Mortgage Default Predictions
  • Vallarta Supermarkets Unveils Second Location with Creativity
  • Societe Generale's Strategic Share Buyback Insights
  • GoodRx Partners with Novo Nordisk to Lower Ozempic Prices
  • Marie Brizard's Monthly Update on Voting Rights and Shares
  • The Remarkable Growth of KKR Stock Over the Past Decade
  • Opendoor's Vision: Building a Retail Investment Revolution
  • Perplexity AI's Bold $34.5 Billion Move to Acquire Chrome
  • Nutex Health Inc. Faces Investigation Over Stock Practices
  • Overview of Voting Rights and Shares for Marie Brizard
  • Exciting Fall Festivities Await at Jellystone Park Locations
  • Class Action Lawsuit Against Lineage, Inc.: What You Need to Know
  • Edelson Lechtzin LLP Launches Investigation into CPAP Data Breach
  • HiLabs Secures HITRUST i1 Certification for Enhanced Data Security
  • Century Complete Launches Modern Model Home in Coastal Paradise
  • The Blossoming Transformation of Galai Village in Xizang
  • GDT Earns Prestigious Award as NetApp's Leading Partner
  • Globant Launches Enterprise AI 2.0 with Advanced AI Marketplace
  • Enhancing Education: KPN and PEPPM Join Forces for Schools
  • Smart Strategies for Purchasing Home Appliances Online
  • Key Questions to Consider When Selecting Flooring
  • Innovative Glasses Holder Designed for Fashion and Function
  • Celebrate National Lemonade Day with Corner Bakery Cafe®
  • Fleet Upfitting Services Set for Significant Growth to USD 12.57B
  • Palo Alto Networks Earnings Analysis: Focus on Growth Strategies
  • Transformative Growth in Xizang's Peach Blossom Village
  • VINCI Secures Major Eastern Freeway Upgrade Contract
  • Exploring Renewable Natural Gas Initiatives by Southwest Gas
  • Future Growth and Trends in the U.S. Glass Cleaner Market
  • Florida Cancer Specialists Enhances Radiation Oncology Services
  • Join Niccolo de Masi at the Entrepreneur Expo for Innovation
  • Vaisala Corporation Engages in Share Repurchase Initiative
  • Fausak Tires & Service Expands with New Alabama Location
  • Understanding the Current Market Sentiment for Teva Pharma
  • Innovative Post Driver Enhances Safety and Efficiency
  • Understanding Investor Sentiment on Stifel Financial's Stock
  • Class Action Lawsuit Filed Over Unpaid Overtime Wages
  • Analyzing Market Trends Surrounding Chipotle Mexican Grill
  • Class Action Filed Against Heritage Hotel Group Over Wages
  • Duolingo Optimizes Learning Experience with AI Enhancements
  • Globant Unveils Revolutionary Enterprise AI 2.0 Platform
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site